CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming
收藏  |  浏览/下载：23/0  |  提交时间：2021/11/01
Phase I dose-escalation and dose-expansion trial of CDK4/6 inhibitor FCN-437c in Chinese female patients with ER+HER2-advanced breast cancer (ABC). 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Zhang, Jian;  Wang, Xiaojia;  Wang, Xian;  Hui, Aimin;  Wu, Zhuli
收藏  |  浏览/下载：22/0  |  提交时间：2021/11/01
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan
收藏  |  浏览/下载：39/0  |  提交时间：2021/06/15
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang
收藏  |  浏览/下载：52/0  |  提交时间：2021/06/15
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) 期刊论文
2018, 卷号: 29, 期号: 8, 页码: 1634-1657
作者:  Cardoso, F.;  Senkus, E.;  Costa, A.;  Papadopoulos, E.;  Aapro, M.
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women 期刊论文
2018, 卷号: 78, 期号: 13
作者:  Xu, Binghe;  Zhang, Qingyuan;  Li, Huiping;  Sun, Wan;  Li, Wei
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Xu, Binghe;  Zhang, Qingyuan;  Li, Huiping;  Sun, Wan;  Li, Wei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏  |  浏览/下载：10/0  |  提交时间：2020/10/26
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 期刊论文
2017, 卷号: 28, 期号: 1, 页码: 16-33
作者:  Cardoso F;  Costa A;  Senkus E;  Aapro M;  André F
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace